GnRH agonists in the treatment of endometriosis

L. Fedele, S. Bianchi, L. Arcaini, P. Vercellini, G. B. Candiani

Research output: Contribution to journalArticlepeer-review

Abstract

GnRH agonists, synthetic analogs of GnRH, desensitize pituitary receptors for the native molecule, thus causing reversible hypogonatropic hypogonadism. Numerous clinical studies have suggested that these compounds are efficacious in the treatment of endomeytriosis, but it is not clear whether they are superior to the other drugs used in treatment of this disease. The frequency of recurrence of pain symptoms at the end of treatment is high and the data on recovery of fertility are conflicting. Long-term administration of GnRH agonists is a safe and well tolerated treatment but its role in the management of endometriosis is still not well defined.

Original languageEnglish
Pages (from-to)5-12
Number of pages8
JournalActa Europaea Fertilitatis
Volume19
Issue number1
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'GnRH agonists in the treatment of endometriosis'. Together they form a unique fingerprint.

Cite this